Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.

MLA

Kahn, Justine M., et al. “Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.” Journal of Pediatric Hematology/Oncology Nursing, vol. 40, no. 1, Jan. 2023, pp. 17–23. EBSCOhost, https://doi.org/10.1177/27527530221122685.

APA

Kahn, J. M., Stevenson, K., Beauchemin, M., Koch, V. B., Cole, P. D., Welch, J. J. G., Gage-Bouchard, E., Karsenty, C., Silverman, L. B., Kelly, K. M., & Bona, K. (2023). Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. Journal of Pediatric Hematology/Oncology Nursing, 40(1), 17–23. https://doi.org/10.1177/27527530221122685

Chicago

Kahn, Justine M, Kristen Stevenson, Melissa Beauchemin, Victoria B Koch, Peter D Cole, Jennifer J G Welch, Elizabeth Gage-Bouchard, et al. 2023. “Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.” Journal of Pediatric Hematology/Oncology Nursing 40 (1): 17–23. doi:10.1177/27527530221122685.